Chinese money floods US biotech as Beijing chases new cures

Chinese money floods US biotech as Beijing chases new cures


China is cutting its tariffs on certain drugs and shortening the approval process for clinical trials to encourage medical investment ties with the US. Chinese investors are pumping money into US drug startups as Beijing seeks to become a global leader in new medicines, adding to a flood of cash flowing to groundbreaking health firms.



from Biotech News